oral tirzepatide versus injection vs 𝗠𝗼𝘀𝘁 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮𝘀𝘀𝘂𝗺𝗲 𝘁𝗵𝗲 𝘄𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗽𝗶𝗹𝗹 𝘄𝗼𝗿𝗸𝘀 𝗷𝘂𝘀𝘁 𝗮𝘀 𝘄𝗲𝗹𝗹 𝗮𝘀 𝘁𝗵𝗲 𝗶𝗻𝗷𝗲𝗰𝘁𝗶𝗼𝗻. That's not what the latest research shows 📊 📚 In a large 2026 analysis Oral Tirzepatide vs Injection: Which

Semaglutide contains GLP-1 as its active ingredient

Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wober C, Pemp B, Bsteh G (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

8 Future directions The advancement of GLP-1 receptor agonists is progressing towards more refined treatment strategies, with tirzepatide at the forefront of research as a dual GIP/GLP-1 receptor agonist (Nauck and DAlessio 2022)

Important safety information: Mounjaro (tirzepatide) and Ozempic (semaglutide) are prescription-only medications